Cytopenias in pediatric kidney transplant recipients: preceding factors and clinical consequences

Shira Regev-Sadeh, Yael Borovitz*, Orna Steinberg-Shemer, Oded Gilad, Shoval Shoham, Joanne Yacobovich

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Background: Kidney transplantation is associated with secondary complications, including the risk of developing posttransplant cytopenias. This study aimed to evaluate the characteristics, identify predictors, and assess the management and consequences of cytopenias in the pediatric kidney transplant population. Methods: This is a single-center retrospective analysis of 89 pediatric kidney transplant recipients. Possible factors preceding cytopenias were compared with the goal of recognizing predictors for posttransplant cytopenias. Posttransplant neutropenias were analyzed for the total study period and separately for the period beyond 6 months posttransplant (late neutropenias), to rule out confounding influences of induction and initial intensive therapy. Results: Sixty patients (67%) developed at least one episode of posttransplant cytopenia. All episodes of posttransplant thrombocytopenias were mild or moderate. Posttransplant infections and graft rejection were found to be significant predictors for thrombocytopenia (HR 6.06, 95% CI 1.6–22.9, and HR 5.82, 95% CI 1.27–26.6, respectively). A total of 30% of posttransplant neutropenias were severe (ANC ≤ 500). Pretransplant dialysis and posttransplant infections were significant predictors for late neutropenias (HR 11.2, 95% CI 1.45–86.4, and HR 3.32, 95% CI 1.46–7.57, respectively). Graft rejection occurred in 10% of patients with cytopenia, all following neutropenia, within 3 months from cytopenia appearance. In all such cases, mycophenolate mofetil dosing had been held or reduced prior to rejection. Conclusions: Posttransplant infections are substantial contributors to developing posttransplant cytopenias. Preemptive transplantation appears to reduce risk of late neutropenia, the accompanying reduction in immunosuppressive therapy, and the ensuing risk of graft rejection. An alternative response to neutropenia, possibly using granulocyte colony stimulating factor, may diminish graft rejection. Graphical abstract: [Figure not available: see fulltext.].

Original languageEnglish
Pages (from-to)3445-3454
Number of pages10
JournalPediatric Nephrology
Issue number10
StatePublished - Oct 2023


  • Children
  • Kidney transplantation
  • Neutropenia
  • Rejection
  • Thrombocytopenia


Dive into the research topics of 'Cytopenias in pediatric kidney transplant recipients: preceding factors and clinical consequences'. Together they form a unique fingerprint.

Cite this